Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial

التفاصيل البيبلوغرافية
العنوان: Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
المؤلفون: Asim Shabbir, Huili Zheng, Wee Yao Koh, Jiade Lu, Jimmy Bok Yan So, Jeremy Tey, Keith Hsiu Chin Lim, Ivan Weng Keong Tham, Cheng N. Leong, Yu Y. Soon
المصدر: Cancer Medicine, Vol 8, Iss 4, Pp 1447-1458 (2019)
Cancer Medicine
بيانات النشر: Wiley, 2019.
سنة النشر: 2019
مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Nausea, medicine.medical_treatment, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Quality of life, palliative, Stomach Neoplasms, medicine, Humans, Radiology, Nuclear Medicine and imaging, Adverse effect, radiotherapy, Original Research, Aged, Aged, 80 and over, business.industry, gastric cancer, Palliative Care, Cancer, Clinical Cancer Research, Middle Aged, medicine.disease, bleeding, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Dysphagia, Survival Analysis, humanities, Surgery, Radiation therapy, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Vomiting, Quality of Life, Female, Dose Fractionation, Radiation, Gastritis, medicine.symptom, business
الوصف: To evaluate the response and quality of life of palliative gastric radiotherapy in patients with symptomatic locally advanced gastric cancer. Patients with bleeding, pain or obstruction and were treated with palliative gastric radiotherapy to a dose of 36 Gy in 12 daily fractions. The primary outcomes were symptom response rates. Secondary outcomes included overall survival, adverse events and proportion of patients with ≥10‐point absolute improvement in the fatigue, nausea/vomiting and pain subscales in the EORTC Qualify of Life Questionnaire C30 (EORTC QLQ‐C30) and dysphagia/pain subscales in the gastric specific module (STO22) at the end of RT and 1 month after the completion of radiotherapy. Fifty patients were accrued. Median survival duration was 85 days. 40/50 patients (80%) with bleeding, 2/2 (100%) patients with obstruction and 1/1 (100%) patient with pain responded to radiotherapy. Improvements fatigue, nausea/vomiting and pain subscales of the EORTC QLQ‐C30 was seen in 50%, 28% and 44% of patients at the end of RT and in 63%, 31% and 50% of patients 1 month after RT. Improvements in dysphagia/pain subscales of the STO22 was seen in 42% and 28% of patients at then end of RT and 44% and 19% of patients 1 month after RT. Two patients (5%) had grade 3 anorexia and gastritis. Palliative gastric radiotherapy was effective, well tolerated and resulted in improvement in fatigue, dysphagia and pain at the end of radiotherapy and 1 month after the completion of radiotherapy in a significant proportion of patients.
اللغة: English
تدمد: 2045-7634
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb91a468bfbe1050f1088f90c92db80f
https://doaj.org/article/464e52b4a8a349d0a308bd16cdf22e17
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....cb91a468bfbe1050f1088f90c92db80f
قاعدة البيانات: OpenAIRE